AJP - Cell Physiology, Vol 267, Issue 4 C886-C892, Copyright © 1994 by American Physiological Society

ARTICLES

Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients

D. Ferrari, M. Munerati, L. Melchiorri, S. Hanau, F. di Virgilio and O. R. Baricordi
Institute of General Pathology, University of Ferrara, Italy.

We have observed a striking difference in the response to extracellular ATP in lymphoblastoid cell lines established from Duchenne muscular dystrophy patients and normal subjects. Duchenne muscular dystrophy cells stimulated by extracellular ATP underwent a large increase in the cytoplasmic Ca2+ concentration ([Ca2+]i) and plasma membrane depolarization, while normal cell lines were little or not at all responsive. These changes in intracellular ion homeostasis were due to activation of an ATP-gated membrane channel permeable to Na+ and Ca2+, with little or no contribution of Ca2+ release from intracellular stores. The channel was selectively activated by ATP, since other purine/pyrimidine nucleotides were ineffective, and it was inhibited by pretreatment with oxidized ATP, a compound previously reported to irreversibly inhibit P2 purinergic receptors. In the presence of extracellular ATP, lymphoblastoid cells established from Duchenne muscular dystrophy patients, but not from healthy controls, underwent rounding and swelling and eventually lysed. The results of this study suggest that lymphoblastoid cells isolated from Duchenne muscular dystrophy patients are eminently sensitive to stimulation by extracellular ATP.

This article has been cited by other articles:

				G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF]

				K. Sak, J.-M. Boeynaems, and H. Everaus Involvement of P2Y receptors in the differentiation of haematopoietic cells J. Leukoc. Biol., April 1, 2003; 73(4): 442 - 447. [Abstract] [Full Text] [PDF]

				E. Adinolfi, L. Melchiorri, S. Falzoni, P. Chiozzi, A. Morelli, A. Tieghi, A. Cuneo, G. Castoldi, F. Di Virgilio, and O. R. Baricordi P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia Blood, January 15, 2002; 99(2): 706 - 708. [Abstract] [Full Text] [PDF]

				F. Di Virgilio, P. Chiozzi, D. Ferrari, S. Falzoni, J. M. Sanz, A. Morelli, M. Torboli, G. Bolognesi, and O. R. Baricordi Nucleotide receptors: an emerging family of regulatory molecules in blood cells Blood, February 1, 2001; 97(3): 587 - 600. [Abstract] [Full Text] [PDF]

				D. FERRARI, A. LA SALA, P. CHIOZZI, A. MORELLI, S. FALZONI, G. GIROLOMONI, M. IDZKO, S. DICHMANN, J. NORGAUER, and F. DI VIRGILIO The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release FASEB J, December 1, 2000; 14(15): 2466 - 2476. [Abstract] [Full Text]

				O. R. Baricordi, L. Melchiorri, E. Adinolfi, S. Falzoni, P. Chiozzi, G. Buell, and F. Di Virgilio Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor J. Biol. Chem., November 19, 1999; 274(47): 33206 - 33208. [Abstract] [Full Text] [PDF]

				B. D. Humphreys, C. Virginio, A. Surprenant, J. Rice, and G. R. Dubyak Isoquinolines as Antagonists of the P2X7 Nucleotide Receptor: High Selectivity for the Human versus Rat Receptor Homologues Mol. Pharmacol., July 1, 1998; 54(1): 22 - 32. [Abstract] [Full Text]